ESR1 and breast cancer: When we compared the immune marker correlation for ESR1 and ESR2 specifically in breast cancer, it is striking that unlike ESR2, ESR1 in general exhibits a negative association with these antitumor immune markers (compare online supplemental figure S8D, E), supporting the notion that ERα and ERβ play opposite roles in tumor immune microenvironment.